Pulmonary applications and toxicity of engineered nanoparticles

Jeffrey W Card1, Darryl C Zeldin, James C Bonner

  • 1Cantox Health Sciences International, 2233 Argentia Rd., Suite 308, Mississauga, Ontario, Canada L5N 2X7. jcard@cantox.com

Summary

Engineered nanoparticles offer advanced respiratory research and drug delivery but may cause lung toxicity. Further study is needed to balance their benefits against potential pulmonary risks.

Related Concept Videos